Multicentre prospective observational study exploring the predictive value of functional echocardiographic indices for early identification of preterm neonates at risk of developing chronic pulmonary hypertension secondary to chronic neonatal lung disease.

Details

Serval ID
serval:BIB_8D2882817ACC
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Multicentre prospective observational study exploring the predictive value of functional echocardiographic indices for early identification of preterm neonates at risk of developing chronic pulmonary hypertension secondary to chronic neonatal lung disease.
Journal
BMJ open
Author(s)
Thomas L., Baczynski M., Deshpande P., Kharrat A., Joye S., Zhu F., Ibarra-Rios D., Shah P.S., Mertens L., Jankov R.P., Ye X.Y., Neary E., Ting J., Castaldo M., Levy P., Smith A., El-Khuffash A.F., Giesinger R.E., McNamara P.J., Weisz D.E., Jain A.
ISSN
2044-6055 (Electronic)
ISSN-L
2044-6055
Publication state
Published
Issued date
31/03/2021
Peer-reviewed
Oui
Volume
11
Number
3
Pages
e044924
Language
english
Notes
Publication types: Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Abstract
Although chronic pulmonary hypertension (cPH) secondary to chronic neonatal lung disease is associated with increased mortality and respiratory and neurodevelopmental morbidities, late diagnosis (typically ≥36 weeks postmenstrual age, PMA) and the use of qualitative echocardiographic diagnostic criterion (flat interventricular septum in systole) remain significant limitations in clinical care. Our objective in this study is to evaluate the utility of relevant quantitative echocardiographic indices to identify cPH in preterm neonates, early in postnatal course and to develop a diagnostic test based on the best combination of markers.
In this ongoing international prospective multicentre observational diagnostic accuracy study, we aim to recruit 350 neonates born <27 weeks PMA and/or birth weight <1000 g and perform echocardiograms in the third week of age and at 32 weeks PMA (early diagnostic assessments, EDA) in addition to the standard diagnostic assessment (SDA) for cPH at 36 weeks PMA. Predefined echocardiographic markers under investigation will be measured at each EDA and examined to create a scoring system to identify neonates who subsequently meet the primary outcome of cPH/death at SDA. Diagnostic test characteristics will be defined for each EDA. Pulmonary artery acceleration time and tricuspid annular plane systolic excursion are the primary markers of interest.
Ethics approval has been received by the Mount Sinai Hospital Research Ethics Board (REB) (#16-0111-E), Sunnybrook Health Sciences Centre REB (#228-2016), NHS Health Research Authority (IRAS 266498), University of Iowa Human Subjects Office/Institutional Review Board (201903736), Rotunda Hospital Research and Ethics Committee (REC-2019-008), and UBC Children's and Women's REB (H19-02738), and is under review at Boston Children's Hospital Institutional Review Board. Study results will be disseminated to participating families in lay format, presented to the scientific community at paediatric and critical care conferences and published in relevant peer-reviewed journals.
NCT04402645.
Keywords
Boston, Child, Echocardiography, Female, Humans, Hypertension, Pulmonary/diagnostic imaging, Hypertension, Pulmonary/etiology, Infant, Infant, Newborn, Lung Diseases, Prospective Studies, echocardiography, neonatal intensive & critical care, paediatric cardiology
Pubmed
Web of science
Open Access
Yes
Create date
24/04/2021 15:34
Last modification date
19/12/2023 8:12
Usage data